Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 04/17/24 EDT

48.30UNCH (UNCH)

Volume

10,171,942

52 week range

47.58 - 70.93

Open47.93
Day High48.40
Day Low47.62
Prev Close48.30
52 Week High70.93
52 Week High Date04/25/23
52 Week Low47.58
52 Week Low Date02/06/24

Key Stats

Market Cap97.892B
Shares Out2.03B
10 Day Average Volume11.32M
Dividend2.40
Dividend Yield4.97%
Beta0.42
YTD % Change-5.87

KEY STATS

Open47.93
Day High48.40
Day Low47.62
Prev Close48.30
52 Week High70.93
52 Week High Date04/25/23
52 Week Low47.58
52 Week Low Date02/06/24
Market Cap97.892B
Shares Out2.03B
10 Day Average Volume11.32M
Dividend2.40
Dividend Yield4.97%
Beta0.42
YTD % Change-5.87

RATIOS/PROFITABILITY

EPS (TTM)3.86
P/E (TTM)12.52
Fwd P/E (NTM)66.53
EBITDA (TTM)20.625B
ROE (TTM)26.53%
Revenue (TTM)45.006B
Gross Margin (TTM)76.44%
Net Margin (TTM)17.86%
Debt To Equity (MRQ)135.14%

EVENTS

Earnings Date04/25/2024(est)
Ex Div Date04/04/2024
Div Amount0.60
Split Date-
Split Factor-

Latest On Bristol-Myers Squibb Co

These are the 10 most overvalued stocks in the S&P 50012 Hours AgoCNBC.com
These are the top 5 companies to work for in India, according to LinkedInApril 15, 2024CNBC.com
Biotech stocks are ready to break out. They just need one more thingApril 10, 2024CNBC.com
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rivalApril 9, 2024CNBC.com
Jim Cramer lays out his top small-cap healthcare picksApril 5, 2024CNBC.com

Content From Our Affiliates

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY)20 Hours AgoTipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF)April 12, 2024TipRanks
Bristol-Myers Squibb: A Buy Rating on Undervaluation and Promising Product PortfolioApril 12, 2024TipRanks
Hold Rating on Bristol-Myers Squibb Amid Promising Yet Incomplete KarXT Schizophrenia Trial DataApril 10, 2024TipRanks
Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 monthsApril 8, 2024TipRanks

Profile

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric...

Christopher Boerner Ph.D.

Chairman of the Board, Chief Executive Officer, Chief Operating Officer

David Elkins

Executive Vice President, Chief Financial Officer, Member of the Leadership Team

Karin Shanahan

Executive Vice President, Global Product Development & Supply, Member of the Leadership Team

Elizabeth Mily

Executive Vice President - Strategy and Business Development, Member of the Leadership Team

Sandra Leung

Executive Vice President, General Counsel, Member of the Leadership Team

Address

Route 206 And Province Line Road

Princeton, NJ

08543

United States

https://www.bms.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
SNY Sanofi SA	45.39	UNCH	UNCH
GSK GSK plc	39.27	UNCH	UNCH
GILD Gilead Sciences Inc	66.16	UNCH	UNCH
PFE Pfizer Inc	25.39	UNCH	UNCH
AMGN Amgen Inc	262.75	UNCH	UNCH